• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

唾液腺癌的治疗管理:ASCO 指南。

Management of Salivary Gland Malignancy: ASCO Guideline.

机构信息

Cleveland Clinic, Cleveland, OH.

American Society of Clinical Oncology, Alexandria, VA.

出版信息

J Clin Oncol. 2021 Jun 10;39(17):1909-1941. doi: 10.1200/JCO.21.00449. Epub 2021 Apr 26.

DOI:10.1200/JCO.21.00449
PMID:33900808
Abstract

PURPOSE

To provide evidence-based recommendations for practicing physicians and other healthcare providers on the management of salivary gland malignancy.

METHODS

ASCO convened an Expert Panel of medical oncology, surgical oncology, radiation oncology, neuroradiology, pathology, and patient advocacy experts to conduct a literature search, which included systematic reviews, meta-analyses, randomized controlled trials, and prospective and retrospective comparative observational studies published from 2000 through 2020. Outcomes of interest included survival, diagnostic accuracy, disease recurrence, and quality of life. Expert Panel members used available evidence and informal consensus to develop evidence-based guideline recommendations.

RESULTS

The literature search identified 293 relevant studies to inform the evidence base for this guideline. Six main clinical questions were addressed, which included subquestions on preoperative evaluations, surgical diagnostic and therapeutic procedures, appropriate radiotherapy techniques, the role of systemic therapy, and follow-up evaluations.

RECOMMENDATIONS

When possible, evidence-based recommendations were developed to address the diagnosis and appropriate preoperative evaluations for patients with a salivary gland malignancy, therapeutic procedures, and appropriate treatment options in various salivary gland histologies.Additional information is available at www.asco.org/head-neck-cancer-guidelines.

摘要

目的

为临床医生和其他医疗保健提供者提供有关唾液腺癌管理的循证推荐意见。

方法

美国临床肿瘤学会(ASCO)召集了肿瘤内科、肿瘤外科、放射肿瘤学、神经放射学、病理学和患者权益倡导专家组成专家小组,对 2000 年至 2020 年发表的系统评价、荟萃分析、随机对照试验和前瞻性及回顾性对照观察研究进行了文献检索。感兴趣的结局包括生存、诊断准确性、疾病复发和生活质量。专家小组成员利用现有证据和非正式共识制定了基于证据的指南推荐意见。

结果

文献检索确定了 293 项相关研究,为该指南的循证基础提供了信息。共提出了 6 个主要临床问题,其中包括唾液腺癌患者术前评估、手术诊断和治疗程序、适当的放疗技术、全身治疗的作用以及随访评估等方面的亚问题。

推荐意见

当有可能时,制定了循证推荐意见,以解决唾液腺癌患者的诊断和适当的术前评估、治疗程序以及各种唾液腺组织学的适当治疗选择。更多信息可在 www.asco.org/head-neck-cancer-guidelines 上获取。

相似文献

1
Management of Salivary Gland Malignancy: ASCO Guideline.唾液腺癌的治疗管理:ASCO 指南。
J Clin Oncol. 2021 Jun 10;39(17):1909-1941. doi: 10.1200/JCO.21.00449. Epub 2021 Apr 26.
2
Diagnosis and Management of Squamous Cell Carcinoma of Unknown Primary in the Head and Neck: ASCO Guideline.头颈部不明原发灶鳞状细胞癌的诊断和治疗:ASCO 指南。
J Clin Oncol. 2020 Aug 1;38(22):2570-2596. doi: 10.1200/JCO.20.00275. Epub 2020 Apr 23.
3
Immunotherapy and Biomarker Testing in Recurrent and Metastatic Head and Neck Cancers: ASCO Guideline.免疫治疗和生物标志物检测在复发性和转移性头颈部癌症中的应用:ASCO 指南。
J Clin Oncol. 2023 Feb 10;41(5):1132-1146. doi: 10.1200/JCO.22.02328. Epub 2022 Dec 15.
4
Chemotherapy in Combination With Radiotherapy for Definitive-Intent Treatment of Stage II-IVA Nasopharyngeal Carcinoma: CSCO and ASCO Guideline.《CSCO/ASCO 鼻咽癌临床诊疗指南》:放化疗用于局部晚期鼻咽癌的根治性治疗
J Clin Oncol. 2021 Mar 1;39(7):840-859. doi: 10.1200/JCO.20.03237. Epub 2021 Jan 6.
5
Management of the Neck in Squamous Cell Carcinoma of the Oral Cavity and Oropharynx: ASCO Clinical Practice Guideline.口腔和口咽鳞状细胞癌颈部管理:ASCO 临床实践指南。
J Clin Oncol. 2019 Jul 10;37(20):1753-1774. doi: 10.1200/JCO.18.01921. Epub 2019 Feb 27.
6
Treatment of Malignant Pleural Mesothelioma: American Society of Clinical Oncology Clinical Practice Guideline.恶性胸膜间皮瘤的治疗:美国临床肿瘤学会临床实践指南。
J Clin Oncol. 2018 May 1;36(13):1343-1373. doi: 10.1200/JCO.2017.76.6394. Epub 2018 Jan 18.
7
Management of Stage III Non-Small-Cell Lung Cancer: ASCO Guideline.III 期非小细胞肺癌的管理:ASCO 指南。
J Clin Oncol. 2022 Apr 20;40(12):1356-1384. doi: 10.1200/JCO.21.02528. Epub 2021 Dec 22.
8
Systemic Therapy for Small-Cell Lung Cancer: ASCO-Ontario Health (Cancer Care Ontario) Guideline.小细胞肺癌的系统治疗:ASCO-安大略省健康(安大略省癌症护理)指南。
J Clin Oncol. 2023 Dec 10;41(35):5448-5472. doi: 10.1200/JCO.23.01435. Epub 2023 Oct 11.
9
[Interpretation and comparison of international guidelines for salivary gland malignancy in 2021].《2021年涎腺恶性肿瘤国际指南解读与比较》
Zhonghua Kou Qiang Yi Xue Za Zhi. 2022 Feb 9;57(2):136-141. doi: 10.3760/cma.j.cn112144-20210715-00331.
10
Treatment of Multiple Myeloma: ASCO and CCO Joint Clinical Practice Guideline.多发性骨髓瘤的治疗:ASCO 和 CCO 联合临床实践指南。
J Clin Oncol. 2019 May 10;37(14):1228-1263. doi: 10.1200/JCO.18.02096. Epub 2019 Apr 1.

引用本文的文献

1
Lenvatinib in advanced thyroid, salivary gland, endometrial, and hepatocellular carcinomas: a real-world study on treatment duration and toxicity management.乐伐替尼用于晚期甲状腺癌、唾液腺癌、子宫内膜癌和肝细胞癌:一项关于治疗持续时间和毒性管理的真实世界研究。
Ther Adv Med Oncol. 2025 Sep 12;17:17588359251359905. doi: 10.1177/17588359251359905. eCollection 2025.
2
Two-Scope Technique for Tracheal Epithelial-Myoepithelial Carcinoma-A Rare Case Report and Review.气管上皮-肌上皮癌的双镜技术——1例罕见病例报告及文献复习
Respirol Case Rep. 2025 Sep 7;13(9):e70333. doi: 10.1002/rcr2.70333. eCollection 2025 Sep.
3
Evaluation of deepseek, gemini, ChatGPT-4o, and perplexity in responding to salivary gland cancer.
评估DeepSeek、Gemini、ChatGPT-4o和Perplexity对涎腺癌的回答。
BMC Oral Health. 2025 Aug 23;25(1):1358. doi: 10.1186/s12903-025-06726-4.
4
Evaluation of Inflammatory Biomarkers in Parotid Tumors.腮腺肿瘤中炎症生物标志物的评估
Med Sci Monit. 2025 Aug 17;31:e947334. doi: 10.12659/MSM.947334.
5
Complex Decongestive Therapy With Oral Adenoid Cystic Cancer: A Case Report.口腔腺样囊性癌的综合消肿治疗:一例报告
Clin Case Rep. 2025 Jul 28;13(8):e70662. doi: 10.1002/ccr3.70662. eCollection 2025 Aug.
6
Clinical features and prognostic factors of salivary adenoid cystic and mucoepidermoid carcinomas.涎腺腺样囊性癌和黏液表皮样癌的临床特征及预后因素
Medicine (Baltimore). 2025 Jul 18;104(29):e43409. doi: 10.1097/MD.0000000000043409.
7
Clinical diagnosis, treatment, and survival analysis of 61 cases of salivary duct carcinoma: a retrospective study.61例涎腺导管癌的临床诊断、治疗及生存分析:一项回顾性研究
PeerJ. 2025 Jul 4;13:e19626. doi: 10.7717/peerj.19626. eCollection 2025.
8
TROP2 Expression in Salivary Gland Adenoid Cystic Carcinoma (ACC) According to Histologic Subtype: Therapeutic Implications.根据组织学亚型分析唾液腺腺样囊性癌(ACC)中TROP2的表达:治疗意义
J Oral Pathol Med. 2025 Sep;54(8):658-666. doi: 10.1111/jop.70008. Epub 2025 Jul 8.
9
Surgery Alone without Adjuvant Radiation Therapy for High- or Intermediate-Grade Salivary Gland Cancer.高分级或中分级唾液腺癌单纯手术治疗而非辅助性放射治疗
ORL J Otorhinolaryngol Relat Spec. 2025 Jun 28:1-10. doi: 10.1159/000547198.
10
Potassium Iodide Induces Apoptosis in Salivary Gland Cancer Cells.碘化钾诱导唾液腺癌细胞凋亡。
Int J Mol Sci. 2025 May 28;26(11):5199. doi: 10.3390/ijms26115199.